$ELV
Elevance Health, Inc. Stock $elv

$elv Overview Financials Valuation SEC Filings Company Website

2014 Q1 Form 10-Q Financial Statement

#000115603914000005 Filed on April 30, 2014

Income Statement

Concept	2014 Q1	2013 Q1
Revenue	$17.86B	$17.58B
YoY Change	1.61%	14.02%
Cost Of Revenue	$13.66B	$65.00M
YoY Change	20922.46%
Gross Profit	$4.195B	$17.51B
YoY Change	-76.04%	13.6%
Gross Profit Margin	23.49%	99.63%
Selling, General & Admin	$2.862B	$2.329B
YoY Change	22.86%	7.54%
% of Gross Profit	68.22%	13.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$26.40M	$25.30M
YoY Change	4.35%	7.66%
% of Gross Profit	0.63%	0.14%
Operating Expenses	$2.862B	$2.329B
YoY Change	22.86%	7.54%
Operating Profit	$1.119B	$1.357B
YoY Change	-17.58%	11.93%
Interest Expense	$146.2M	$153.5M
YoY Change	-4.76%	40.7%
% of Operating Profit	13.07%	11.31%
Other Income/Expense, Net
YoY Change
Pretax Income	$1.130B	$1.283B
YoY Change	-11.88%	-2.08%
Income Tax	$438.7M	$410.2M
% Of Pretax Income	38.82%	31.98%
Net Earnings	$701.0M	$885.2M
YoY Change	-20.81%	3.35%
Net Earnings / Revenue	3.93%	5.04%
Basic Earnings Per Share	$2.46	$2.92
Diluted Earnings Per Share	$2.40	$2.89
COMMON SHARES
Basic Shares Outstanding	284.9M shares	303.2M shares
Diluted Shares Outstanding	292.6M shares	305.9M shares

Balance Sheet

Concept	2014 Q1	2013 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.98B	$19.48B
YoY Change	2.55%	5.43%
Cash & Equivalents	$1.971B	$1.660B
Short-Term Investments	$18.00B	$17.82B
Other Short-Term Assets	$2.418B	$1.891B
YoY Change	27.85%	-1.54%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$31.81B	$28.66B
YoY Change	10.98%	4.06%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.812B	$1.738B
YoY Change	4.23%	19.49%
Goodwill	$16.92B	$17.49B
YoY Change	-3.28%	26.2%
Intangibles	$8.387B	$9.056B
YoY Change	-7.38%	14.95%
Long-Term Investments	$22.12B	$21.17B
YoY Change	4.48%	12.87%
Other Assets	$635.8M	$483.3M
YoY Change	31.55%	8.44%
Total Long-Term Assets	$29.88B	$30.75B
YoY Change	-2.83%	23.22%
TOTAL ASSETS
Total Short-Term Assets	$31.81B	$28.66B
Total Long-Term Assets	$29.88B	$30.75B
Total Assets	$61.69B	$59.41B
YoY Change	3.83%	13.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.113B	$2.937B
YoY Change	40.04%	4.52%
Accrued Expenses	$98.00M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$590.0M	$350.0M
YoY Change	68.57%	250.0%
Long-Term Debt Due	$518.7M	$399.4M
YoY Change	29.87%	-56.15%
Total Short-Term Liabilities	$18.49B	$16.03B
YoY Change	15.37%	0.47%
LONG-TERM LIABILITIES
Long-Term Debt	$13.93B	$14.03B
YoY Change	-0.7%	65.79%
Other Long-Term Liabilities	$832.4M	$971.8M
YoY Change	-14.34%	-5.19%
Total Long-Term Liabilities	$14.76B	$15.00B
YoY Change	-1.58%	58.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$18.49B	$16.03B
Total Long-Term Liabilities	$14.76B	$15.00B
Total Liabilities	$37.34B	$35.09B
YoY Change	6.41%	21.14%
SHAREHOLDERS EQUITY
Retained Earnings	$14.01B	$13.28B
YoY Change	5.55%	11.36%
Common Stock	$2.900M	$3.000M
YoY Change	-3.33%	-9.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$24.35B	$24.32B
YoY Change
Total Liabilities & Shareholders Equity	$61.69B	$59.41B
YoY Change	3.83%	13.17%

Cashflow Statement

Concept	2014 Q1	2013 Q1
OPERATING ACTIVITIES
Net Income	$701.0M	$885.2M
YoY Change	-20.81%	3.35%
Depreciation, Depletion And Amortization	$26.40M	$25.30M
YoY Change	4.35%	7.66%
Cash From Operating Activities	$1.388B	$956.9M
YoY Change	45.0%	-21.76%
INVESTING ACTIVITIES
Capital Expenditures	$135.7M	$107.5M
YoY Change	26.23%	-13.17%
Acquisitions	$0.00	$0.00
YoY Change		-100.0%
Other Investing Activities	$100.0K	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$744.3M	-$1.196B
YoY Change	-37.75%	-6048.26%
FINANCING ACTIVITIES
Cash Dividend Paid	$123.4M	$113.4M
YoY Change	8.82%	18.37%
Common Stock Issuance & Retirement, Net	$1.263B	$340.2M
YoY Change	271.19%	-49.96%
Debt Paid & Issued, Net	$24.20M	$556.9M
YoY Change	-95.65%	58.75%
Cash From Financing Activities	-$258.6M	-$579.1M
YoY Change	-55.34%	-50.38%
NET CHANGE
Cash From Operating Activities	$1.388B	$956.9M
Cash From Investing Activities	-$744.3M	-$1.196B
Cash From Financing Activities	-$258.6M	-$579.1M
Net Change In Cash	$384.6M	-$817.8M
YoY Change	-147.03%	-1173.23%
FREE CASH FLOW
Cash From Operating Activities	$1.388B	$956.9M
Capital Expenditures	$135.7M	$107.5M
Free Cash Flow	$1.252B	$849.4M
YoY Change	47.37%	-22.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	3426300000	USD
CY2014Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4113100000	USD
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2014Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	97700000	USD
CY2014Q1	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	173600000	USD
CY2013Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	168800000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	838000000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	649300000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	-34400000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax	-31600000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-41100000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax	-53700000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	1300000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-700000	USD
CY2014Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	327400000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	183200000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	342500000	USD
CY2013Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10765200000	USD
CY2014Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	10003500000	USD
CY2014Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	190300000	USD
CY2013Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	186700000	USD
CY2013Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-4000000	USD
CY2013Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	62200000	USD
CY2014Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	54000000	USD
CY2014Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11500000	shares
CY2013Q4	us-gaap	Assets Assets	59574500000	USD
CY2014Q1	us-gaap	Assets Assets	61685500000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	29745800000	USD
CY2014Q1	us-gaap	Assets Current AssetsCurrent	31806800000	USD
CY2014Q1	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	0	USD
CY2013Q4	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	906900000	USD
CY2014Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	20500900000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	19254900000	USD
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	18478500000	USD
CY2014Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	19506200000	USD
CY2014Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses	-30600000	USD
CY2013	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLosses	-33300000	USD
CY2013	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses	-244500000	USD
CY2014Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLosses	-131200000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	6636900000	USD
CY2014Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	5286700000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	301700000	USD
CY2014Q1	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	449900000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	16826700000	USD
CY2014Q1	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	17600800000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	17038200000	USD
CY2014Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	18004000000	USD
CY2013Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	449900000	USD
CY2014Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	502400000	USD
CY2014Q1	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	1963500000	USD
CY2013Q4	us-gaap	Available For Sale Securities Equity Securities Current AvailableForSaleSecuritiesEquitySecuritiesCurrent	1735500000	USD
CY2013Q4	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	31300000	USD
CY2014Q1	us-gaap	Available For Sale Securities Equity Securities Noncurrent AvailableForSaleSecuritiesEquitySecuritiesNoncurrent	31000000	USD
CY2014Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	82900000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	107000000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	90200000	USD
CY2014Q1	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	41200000	USD
CY2014Q1	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	1156500000	USD
CY2013	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	1054200000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	1324300000	USD
CY2014Q1	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	161800000	USD
CY2013Q1	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	53100000	USD
CY2014Q1	us-gaap	Available For Sale Securities Income Tax Expense On Change In Unrealized Holding Gain Or Loss AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss	67500000	USD
CY2013Q1	us-gaap	Available For Sale Securities Income Tax Expense On Change In Unrealized Holding Gain Or Loss AvailableForSaleSecuritiesIncomeTaxExpenseOnChangeInUnrealizedHoldingGainOrLoss	2400000	USD
CY2014Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain Loss1 AvailableforsaleSecuritiesGrossUnrealizedGainLoss1	994700000	USD
CY2013Q1	us-gaap	Availableforsale Securities Gross Unrealized Gain Loss1 AvailableforsaleSecuritiesGrossUnrealizedGainLoss1	1271200000	USD
CY2014Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	16729300000	USD
CY2013Q1	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	16293500000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1582100000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1971200000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1659600000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	1586900000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	1665300000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	2484600000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value Including Discontinued Operations CashAndCashEquivalentsAtCarryingValueIncludingDiscontinuedOperations	1971200000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	384300000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-819300000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q1	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	13.3135
CY2013Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.375
CY2014Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.4375
CY2014Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2014Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2014Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	281912262	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	293273830	shares
CY2014Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	281912262	shares
CY2013Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	293273830	shares
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	2900000	USD
CY2014Q1	us-gaap	Common Stock Value CommonStockValue	2900000	USD
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	845200000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	928600000	USD
CY2014Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	968100000	USD
CY2014Q1	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	543600000	USD
CY2014Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	75.1113
CY2014Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1500000000	USD
CY2014Q1	us-gaap	Debt Instrument Repurchased Face Amount DebtInstrumentRepurchasedFaceAmount	21200000	USD
CY2014Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	531900000	USD
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	9100000	USD
CY2014Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	85200000	USD
CY2014Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2014-03-25
CY2014Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	0	USD
CY2013Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	383000000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	234500000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	34800000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Postretirement Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPostretirementBenefits	27400000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Unrealized Currency Losses DeferredTaxAssetsUnrealizedCurrencyLosses	-400000	USD
CY2014Q1	us-gaap	Deferred Tax Assets Unrealized Currency Losses DeferredTaxAssetsUnrealizedCurrencyLosses	700000	USD
CY2014Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3343100000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3325200000	USD
CY2014Q1	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax	-426400000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Gains Losses Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetGainsLossesBeforeTax	-674800000	USD
CY2014Q1	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Prior Service Cost Credit Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax	8400000	USD
CY2013Q1	us-gaap	Defined Benefit Plan Accumulated Other Comprehensive Income Net Prior Service Cost Credit Before Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax	3700000	USD
CY2014Q1	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue	1324600000	USD
CY2013Q4	us-gaap	Deposits Received For Securities Loaned At Carrying Value DepositsReceivedForSecuritiesLoanedAtCarryingValue	969700000	USD
CY2014Q1	us-gaap	Depreciation Depreciation	26400000	USD
CY2013Q1	us-gaap	Depreciation Depreciation	25300000	USD
CY2014Q1	us-gaap	Derivative Loss On Derivative DerivativeLossOnDerivative	-19400000	USD
CY2013Q1	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax	0	USD
CY2014Q1	us-gaap	Discontinued Operation Provision For Loss Gain On Disposal Before Income Tax DiscontinuedOperationProvisionForLossGainOnDisposalBeforeIncomeTax	-3200000	USD
CY2013Q1	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	-5700000	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	5700000	USD
CY2013Q1	us-gaap	Dividend Payable Date To Be Paid Day Month And Year DividendPayableDateToBePaidDayMonthAndYear	2013-03-25
CY2014Q1	us-gaap	Dividends Common Stock DividendsCommonStock	124900000	USD
CY2013Q1	us-gaap	Dividends Common Stock DividendsCommonStock	114200000	USD
CY2014Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2014-01-28
CY2013Q1	us-gaap	Dividends Payable Date Declared Day Month And Year DividendsPayableDateDeclaredDayMonthAndYear	2013-02-20
CY2014Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2014-03-10
CY2013Q1	us-gaap	Dividends Payable Date Of Record Day Month And Year DividendsPayableDateOfRecordDayMonthAndYear	2013-03-08
CY2014Q1	us-gaap	Early Repayment Of Senior Debt EarlyRepaymentOfSeniorDebt	24200000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.46
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.92
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.89
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.40
CY2014Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-300000	USD
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-1500000	USD
CY2014Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.388
CY2013Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.320
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	4200000	USD
CY2014Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	22400000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	4200000	USD
CY2014Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	22400000	USD
CY2013Q1	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-1400000	USD
CY2014Q1	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-4300000	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	18000000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	900000	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	-2500000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	-1300000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	10000000	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	18300000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	2500000	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	2800000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	10900000	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	0	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3	13100000	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	6500000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	2900000	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	155500000	USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	177900000	USD
CY2013Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	161900000	USD
CY2014Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	196700000	USD
CY2014Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-100000	USD
CY2013Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-700000	USD
CY2013Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2014Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3000000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1943200000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2490700000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	16917200000	USD
CY2014Q1	us-gaap	Goodwill Goodwill	16916700000	USD
CY2013Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	USD
CY2014Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	2100000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	872300000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	691400000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1130100000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1282500000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1282500000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	1130100000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.43
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.88
CY2014Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.37
CY2013Q1	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.85
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	9600000	USD
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	12900000	USD
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.04
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.03
CY2014Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.03
CY2013Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.04
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	410200000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	438700000	USD
CY2014Q1	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	80500000	USD
CY2014Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
CY2013Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	235700000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-137300000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-224000000	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	435600000	USD
CY2014Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	356000000	USD
CY2013Q1	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	12900000	USD
CY2014Q1	us-gaap	Increase Decrease In Collateral Held Under Securities Lending IncreaseDecreaseInCollateralHeldUnderSecuritiesLending	354900000	USD
CY2014Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	545600000	USD
CY2013Q1	us-gaap	Increase Decrease In Insurance Liabilities IncreaseDecreaseInInsuranceLiabilities	70900000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	58600000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	69500000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	10500000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	24500000	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	107400000	USD
CY2013Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	35100000	USD
CY2013Q1	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	30400000	USD
CY2014Q1	us-gaap	Increase Decrease In Outstanding Checks Financing Activities IncreaseDecreaseInOutstandingChecksFinancingActivities	75000000	USD
CY2013Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	397700000	USD
CY2014Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	616000000	USD
CY2014Q1	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	354900000	USD
CY2013Q1	us-gaap	Increase Decrease In Securities Lending Payable IncreaseDecreaseInSecuritiesLendingPayable	12800000	USD
CY2014Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	14600000	USD
CY2013Q1	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	8200000	USD
CY2014Q1	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	250000000	USD
CY2013Q1	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-31100000	USD
CY2014Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	17644800000	USD
CY2013Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	17435100000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8441000000	USD
CY2014Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8387300000	USD
CY2013Q1	us-gaap	Interest Expense InterestExpense	153500000	USD
CY2014Q1	us-gaap	Interest Expense InterestExpense	146200000	USD
CY2013Q4	us-gaap	Liabilities Liabilities	34809300000	USD
CY2014Q1	us-gaap	Liabilities Liabilities	37340200000	USD
CY2014Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61685500000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	59574500000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	16351500000	USD
CY2014Q1	us-gaap	Liabilities Current LiabilitiesCurrent	18493700000	USD
CY2014Q1	us-gaap	Liabilities Of Assets Held For Sale LiabilitiesOfAssetsHeldForSale	0	USD
CY2013Q4	us-gaap	Liabilities Of Assets Held For Sale LiabilitiesOfAssetsHeldForSale	181400000	USD
CY2013Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	6127200000	USD
CY2014Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	6707100000	USD
CY2013Q4	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	723000000	USD
CY2014Q1	us-gaap	Liability For Future Policy Benefits LiabilityForFuturePolicyBenefits	738900000	USD
CY2014Q1	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	8793200000	USD
CY2013Q4	us-gaap	Liability For Future Policy Benefits And Unpaid Claims And Claims Adjustment Expense LiabilityForFuturePolicyBenefitsAndUnpaidClaimsAndClaimsAdjustmentExpense	8263500000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	518000000	USD
CY2014Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	518700000	USD
CY2014Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13932100000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	13573600000	USD
CY2014Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">References to the terms “we”, “our”, “us”, “WellPoint” or the “Company” used throughout these Notes to Consolidated Financial Statements refer to WellPoint, Inc., an Indiana corporation, and unless the context otherwise requires, its direct and indirect subsidiaries.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are one of the largest health benefits companies in terms of medical membership in the United States, serving </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">36.9</font><font style="font-family:inherit;font-size:10pt;"> medical members through our affiliated health plans and approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">66.8</font><font style="font-family:inherit;font-size:10pt;"> individuals through our subsidiaries as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2014</font><font style="font-family:inherit;font-size:10pt;">. We offer a broad spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Our managed care plans include: preferred provider organizations, or PPOs; health maintenance organizations, or HMOs; point-of-service, or POS, plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans, or CDHPs; and hospital only and limited benefit products. In addition, we provide a broad array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. We provide an array of specialty and other insurance products and services such as behavioral health benefit services, dental, vision, life and disability insurance benefits, radiology benefit management, analytics-driven personal health care guidance and long-term care insurance. We also provide services to the Federal Government in connection with the Federal Employee Program, or FEP, and various Medicare programs. We also sold contact lenses, eyeglasses and other ocular products through our 1-800 CONTACTS, Inc., or 1-800 CONTACTS, business, which was divested on January 31, 2014.</font></div><div style="line-height:120%;padding-bottom:12px;padding-top:8px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are an independent licensee of the Blue Cross and Blue Shield Association, or BCBSA, an association of independent health benefit plans. We serve our members as the Blue Cross licensee for California and as the Blue Cross and Blue Shield, or BCBS, licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">30</font><font style="font-family:inherit;font-size:10pt;"> counties in the Kansas City area), Nevada, New Hampshire, New York (as BCBS in </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10</font><font style="font-family:inherit;font-size:10pt;"> New York City metropolitan and surrounding counties, and as Blue Cross or BCBS in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.) and Wisconsin. In a majority of these service areas we do business as Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, and Empire Blue Cross Blue Shield, or Empire Blue Cross (in our New York service areas). We also conduct business through our AMERIGROUP Corporation, or Amerigroup, subsidiary in Florida, Georgia, Kansas, Louisiana, Maryland, Nevada, New Jersey, New York, Tennessee, Texas and Washington. We also serve customers throughout the country as HealthLink, UniCare, and in certain Arizona, California, Nevada, New York and Virginia markets, through our CareMore Health Group, Inc., or CareMore, subsidiary. We are licensed to conduct insurance operations in all </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">50</font><font style="font-family:inherit;font-size:10pt;"> states through our subsidiaries.</font></div></div>
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-579100000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-258600000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-744300000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1195600000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1387500000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	956900000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	701000000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	885200000	USD
CY2014Q1	us-gaap	Net Investment Income NetInvestmentIncome	183700000	USD
CY2013Q1	us-gaap	Net Investment Income NetInvestmentIncome	162000000	USD
CY2014Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	50	states
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1118700000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	1357300000	USD
CY2014Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2417600000	USD
CY2013Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1677500000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	645200000	USD
CY2014Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	635800000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	120200000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	29700000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-200000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-800000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-500000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	144200000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	43400000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	43400000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	144200000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-2900000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-6800000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-4800000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-20100000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	2600000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax	10800000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	80900000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	10500000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	700000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	700000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	400000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	400000	USD
CY2014Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	140300000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	34500000	USD
CY2014Q1	us-gaap	Other Income OtherIncome	9500000	USD
CY2013Q1	us-gaap	Other Income OtherIncome	9400000	USD
CY2013Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1674700000	USD
CY2014Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1805900000	USD
CY2014Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	832400000	USD
CY2013Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	836000000	USD
CY2013Q4	us-gaap	Other Long Term Investments OtherLongTermInvestments	1542600000	USD
CY2014Q1	us-gaap	Other Long Term Investments OtherLongTermInvestments	1593800000	USD
CY2013Q4	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	2073200000	USD
CY2014Q1	us-gaap	Other Policyholder Funds OtherPolicyholderFunds	2020400000	USD
CY2014Q1	us-gaap	Other Receivables OtherReceivables	1234000000	USD
CY2013Q4	us-gaap	Other Receivables OtherReceivables	1063300000	USD
CY2013Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	16300000	USD
CY2014Q1	us-gaap	Other Short Term Investments OtherShortTermInvestments	25900000	USD
CY2013Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	37900000	USD
CY2014Q1	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	10800000	USD
CY2013Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
CY2014Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Before Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossBeforeTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	0	USD
CY2014Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-500000	USD
CY2013Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterestAvailableforsaleSecurities	-2200000	USD
CY2014Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Tax Including Portion Attributable To Noncontrolling Interest OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossTaxIncludingPortionAttributableToNoncontrollingInterest	300000	USD
CY2013Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion In Other Comprehensive Income Loss Tax Including Portion Attributable To Noncontrolling Interest OtherThanTemporaryImpairmentLossesInvestmentsPortionInOtherComprehensiveIncomeLossTaxIncludingPortionAttributableToNoncontrollingInterest	1200000	USD
CY2013Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	37900000	USD
CY2014Q1	us-gaap	Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet	10800000	USD
CY2013Q4	us-gaap	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	95200000	USD
CY2014Q1	us-gaap	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	177500000	USD
CY2014Q1	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	46200000	USD
CY2013Q1	us-gaap	Payments For Derivative Instrument Investing Activities PaymentsForDerivativeInstrumentInvestingActivities	80600000	USD
CY2014Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	100000	USD
CY2013Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2013Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	340200000	USD
CY2014Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1262800000	USD
CY2014Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	123400000	USD
CY2013Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	113400000	USD
CY2014Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	3084800000	USD
CY2013Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	3955500000	USD
CY2013Q1	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	29200000	USD
CY2014Q1	us-gaap	Payments To Acquire Available For Sale Securities Equity PaymentsToAcquireAvailableForSaleSecuritiesEquity	228600000	USD
CY2013Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	127500000	USD
CY2014Q1	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	35400000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	107500000	USD
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	135700000	USD
CY2013Q1	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	13748700000	USD
CY2014Q1	us-gaap	Policyholder Benefits And Claims Incurred Net PolicyholderBenefitsAndClaimsIncurredNet	13664600000	USD
CY2014Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2014Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2014Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	3968700000	USD
CY2014Q1	us-gaap	Premiums And Other Receivables Net PremiumsAndOtherReceivablesNet	4457500000	USD
CY2013Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	16435600000	USD
CY2014Q1	us-gaap	Premiums Earned Net PremiumsEarnedNet	16517000000	USD
CY2014Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications: </font><font style="font-family:inherit;font-size:10pt;">Certain prior period amounts have been reclassified to conform to the current period presentation.</font></div></div>
CY2014Q1	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	740000000	USD
CY2013Q1	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	USD
CY2013Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	490800000	USD
CY2014Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	284300000	USD
CY2014Q1	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	379400000	USD
CY2013Q1	us-gaap	Proceeds From Repayments Of Commercial Paper ProceedsFromRepaymentsOfCommercialPaper	260300000	USD
CY2013Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	7600000	USD
CY2014Q1	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	25600000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	3117600000	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	2401400000	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2061200000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	2531800000	USD
CY2014Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	30300000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Equity ProceedsFromSaleOfAvailableForSaleSecuritiesEquity	87400000	USD
CY2014Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	970000000	USD
CY2013Q1	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	100000000	USD
CY2013Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	23700000	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	130100000	USD
CY2014Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1811700000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1801500000	USD
CY2013Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	16800000	USD
CY2014Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	41700000	USD
CY2013Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	556900000	USD
CY2014Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	24200000	USD
CY2014Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	780000000	USD
CY2013Q1	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	0	USD
CY2014Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	14011500000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	13813900000	USD
CY2014Q1	us-gaap	Revenues Revenues	17859400000	USD
CY2013Q1	us-gaap	Revenues Revenues	17576000000	USD
CY2014Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	1118300000	USD
CY2013Q1	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	990100000	USD
CY2014Q1	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	1325000000	USD
CY2013Q4	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	969800000	USD
CY2013Q1	us-gaap	Selling Expense SellingExpense	385900000	USD
CY2014Q1	us-gaap	Selling Expense SellingExpense	370800000	USD
CY2014Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2861500000	USD
CY2013Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2329100000	USD
CY2014Q1	us-gaap	Senior Notes SeniorNotes	12699200000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	21500000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	38800000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	300000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	63.33
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1300000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	61.81
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	89.43
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3700000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4200000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	63.83
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	72.51
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1500000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	64.15
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0050
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0060
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3500
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3500
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0216
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0125
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6300000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	65.72
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	100000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	62.71
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1700000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	22.20
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.51
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	305900000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	292600000	shares
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	289600000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9600000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	10000000	shares
CY2013Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	65.38
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	69.46
CY2014Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	212600000	USD
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	66.39
CY2014Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	89.44
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y9M
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y0M
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y7M
CY2014Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y11M
CY2014Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	590000000	USD
CY2013Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	400000000	USD
CY2014Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2000000	shares
CY2014Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	142000000	USD
CY2013Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	48400000	USD
CY2014Q1	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	600000000	USD
CY2013Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	1496600000	USD
CY2014Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount	2428200000	USD
CY2014Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	6600000	shares
CY2014Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	14300000	shares
CY2013Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	5500000	shares
CY2013Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	343500000	USD
CY2014Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1262800000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	24765200000	USD
CY2014Q1	us-gaap	Stockholders Equity StockholdersEquity	24345300000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	23802700000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	24318000000	USD
CY2014Q1	us-gaap	Surplus Notes SurplusNotes	24900000	USD
CY2013Q4	us-gaap	Unearned Premiums UnearnedPremiums	822700000	USD
CY2014Q1	us-gaap	Unearned Premiums UnearnedPremiums	1073000000	USD
CY2014Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	-48600000	USD
CY2013Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	-53000000	USD
CY2013Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2700000	shares
CY2014Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	7700000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	303200000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	284900000	shares
CY2014Q1	wlp	Accumulated Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax AccumulatedOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	2000000	USD
CY2013Q1	wlp	Accumulated Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax AccumulatedOtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-1100000	USD
CY2013Q1	wlp	Available For Sale Securities Accumulated Other Comprehensive Income Net Deferred Tax Liability AvailableForSaleSecuritiesAccumulatedOtherComprehensiveIncomeNetDeferredTaxLiability	-433200000	USD
CY2014Q1	wlp	Available For Sale Securities Accumulated Other Comprehensive Income Net Deferred Tax Liability AvailableForSaleSecuritiesAccumulatedOtherComprehensiveIncomeNetDeferredTaxLiability	-345400000	USD
CY2013Q4	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Less Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLessNumberOfPositions	3451	securities
CY2014Q1	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Less Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLessNumberOfPositions	2845	securities
CY2014Q1	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	277	securities
CY2013Q4	wlp	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	250	securities
CY2013Q4	wlp	Available For Sale Securities Debt Maturities Amortized Cost Noncurrent AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostNoncurrent	455900000	USD
CY2014Q1	wlp	Available For Sale Securities Debt Maturities Amortized Cost Noncurrent AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostNoncurrent	504600000	USD
CY2014Q1	wlp	Available For Sale Securities Equity Securities Cost Current AvailableForSaleSecuritiesEquitySecuritiesCostCurrent	1374000000	USD
CY2013Q4	wlp	Available For Sale Securities Equity Securities Cost Current AvailableForSaleSecuritiesEquitySecuritiesCostCurrent	1168500000	USD
CY2014Q1	wlp	Available For Sale Securities Equity Securities Cost Noncurrent AvailableForSaleSecuritiesEquitySecuritiesCostNoncurrent	26800000	USD
CY2013Q4	wlp	Available For Sale Securities Equity Securities Cost Noncurrent AvailableForSaleSecuritiesEquitySecuritiesCostNoncurrent	27400000	USD
CY2013Q1	wlp	Cash Flow Hedging Instruments Accumulated Other Comprehensive Income Net Deferred Tax Asset CashFlowHedgingInstrumentsAccumulatedOtherComprehensiveIncomeNetDeferredTaxAsset	18600000	USD
CY2014Q1	wlp	Cash Flow Hedging Instruments Accumulated Other Comprehensive Income Net Deferred Tax Asset CashFlowHedgingInstrumentsAccumulatedOtherComprehensiveIncomeNetDeferredTaxAsset	17000000	USD
CY2014Q1	wlp	Deferred Net Actuarial Gain Loss Postretirement Benefits DeferredNetActuarialGainLossPostretirementBenefits	-154700000	USD
CY2013Q1	wlp	Deferred Net Actuarial Gain Loss Postretirement Benefits DeferredNetActuarialGainLossPostretirementBenefits	-188300000	USD
CY2014Q1	wlp	Deferred Prior Service Cost Credit Postretirement Benefit Plans DeferredPriorServiceCostCreditPostretirementBenefitPlans	-86200000	USD
CY2013Q1	wlp	Deferred Prior Service Cost Credit Postretirement Benefit Plans DeferredPriorServiceCostCreditPostretirementBenefitPlans	-99800000	USD
CY2014Q1	wlp	Defined Benefit Plan Accumulated Other Comprehensive Income Adjustments Net Of Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeAdjustmentsNetOfTax	-250500000	USD
CY2013Q1	wlp	Defined Benefit Plan Accumulated Other Comprehensive Income Adjustments Net Of Tax DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeAdjustmentsNetOfTax	-406700000	USD
CY2013Q1	wlp	Defined Benefit Plan Accumulated Other Comprehensive Income Net Deferred Tax Asset DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetDeferredTaxAsset	264400000	USD
CY2014Q1	wlp	Defined Benefit Plan Accumulated Other Comprehensive Income Net Deferred Tax Asset DefinedBenefitPlanAccumulatedOtherComprehensiveIncomeNetDeferredTaxAsset	167500000	USD
CY2013Q4	wlp	Liability For Future Policy Benefits Current LiabilityForFuturePolicyBenefitsCurrent	63100000	USD
CY2014Q1	wlp	Liability For Future Policy Benefits Current LiabilityForFuturePolicyBenefitsCurrent	65700000	USD
CY2014Q1	wlp	Number Of Counties In Geographical Region Served As Independent Licensee NumberOfCountiesInGeographicalRegionServedAsIndependentLicensee	10	county
CY2014Q1	wlp	Number Of Counties In State Of Kansas Company Does Not Serve NumberOfCountiesInStateOfKansasCompanyDoesNotServe	30	county
CY2014Q1	wlp	Number Of Individuals Served NumberOfIndividualsServed	66800000	individuals
CY2014Q1	wlp	Number Of Medical Members NumberOfMedicalMembers	36900000	medical_member
CY2014Q1	wlp	Other Net Change In Unrecognized Periodic Benefit Costs For Defined Benefit Pension And Postretirement Benefit Plans Tax Benefit Expense OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense	1900000	USD
CY2013Q1	wlp	Other Net Change In Unrecognized Periodic Benefit Costs For Defined Benefit Pension And Postretirement Benefit Plans Tax Benefit Expense OtherNetChangeInUnrecognizedPeriodicBenefitCostsForDefinedBenefitPensionAndPostretirementBenefitPlansTaxBenefitExpense	4400000	USD
CY2014Q1	wlp	Patient Protection Affordable Care Act Health Insurance Provider Fee PatientProtectionAffordableCareActHealthInsuranceProviderFee	8000000000	USD
CY2014Q1	wlp	Patient Protection Affordable Care Act Health Insurance Provider Fee Estimated Amount PatientProtectionAffordableCareActHealthInsuranceProviderFeeEstimatedAmount	920000000	USD
CY2014Q1	wlp	Patient Protection Affordable Care Act Health Insurance Provider Fee Expense Recognized PatientProtectionAffordableCareActHealthInsuranceProviderFeeExpenseRecognized	230000000	USD
CY2014Q1	wlp	Potentially Dilutive Restricted Stock Units Contingent On Operating Results PotentiallyDilutiveRestrictedStockUnitsContingentOnOperatingResults	700000	shares
CY2013Q1	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	62.41
CY2014Q1	wlp	Stock Repurchased And Retired During Period Average Price StockRepurchasedAndRetiredDuringPeriodAveragePrice	88.14
CY2014Q1	dei	Amendment Flag AmendmentFlag	false
CY2014Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2014Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2014Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
CY2014Q1	dei	Document Period End Date DocumentPeriodEndDate	2014-03-31
CY2014Q1	dei	Document Type DocumentType	10-Q
CY2014Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001156039
CY2014Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	279672290	shares
CY2014Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2014Q1	dei	Entity Registrant Name EntityRegistrantName	WellPoint, Inc.
CY2014Q1	dei	Trading Symbol TradingSymbol	WLP

Files In Submission

Name	View Source	Status
0001156039-14-000005-index-headers.html	Edgar Link	pending
0001156039-14-000005-index.html	Edgar Link	pending
0001156039-14-000005.txt	Edgar Link	pending
0001156039-14-000005-xbrl.zip	Edgar Link	pending
exhibit102p-20140331.htm	Edgar Link	pending
exhibit102q-20140331.htm	Edgar Link	pending
exhibit102r-20140331.htm	Edgar Link	pending
exhibit311-20140331.htm	Edgar Link	pending
exhibit312-20140331.htm	Edgar Link	pending
exhibit321-20140331.htm	Edgar Link	pending
exhibit322-20140331.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
formofincentivecompen_image1.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wlp-20140331.xml	Edgar Link	completed
wlp-20140331.xsd	Edgar Link	pending
wlp-20140331x10q.htm	Edgar Link	pending
wlp-20140331_cal.xml	Edgar Link	unprocessable
wlp-20140331_def.xml	Edgar Link	unprocessable
wlp-20140331_lab.xml	Edgar Link	unprocessable
wlp-20140331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ELV
Elevance Health, Inc. Stock $elv

2014 Q1 Form 10-Q Financial Statement

#000115603914000005 Filed on April 30, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELV Elevance Health, Inc. Stock $elv

2014 Q1 Form 10-Q Financial Statement

#000115603914000005 Filed on April 30, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ELV
Elevance Health, Inc. Stock $elv